Cargando…

A discussion of an issue relating to sample sizes of exact phase II trial designs

Detalles Bibliográficos
Autor principal:	Howman, Andrew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3981509/ http://dx.doi.org/10.1186/1745-6215-14-S1-P70

Ejemplares similares

Experiences in the design and implementation of phase II trials in CLL
por: Cohen, Dena R, et al.
Publicado: (2011)

Sample size optimisation when designing sampling plan for risk assessment relating to adventitious presence of allergens in food
por: Elegbede, CF, et al.
Publicado: (2013)

Model selection and sample size adaptation: HYPAZ trial
por: Bond, Simon, et al.
Publicado: (2011)

Sample size in cluster randomised trials with unequal clusters
por: Holloway, Ivana, et al.
Publicado: (2011)

Interim sample size re-estimation in the IIVOP trial
por: Dawson, Sarah, et al.
Publicado: (2015)

Inadequate reporting of sample size calculations in cluster randomised trials: a review
por: Rutterford, Clare, et al.
Publicado: (2013)

Phase II trial designs for complex interventions: a single-arm single-stage design for clustered continuous outcomes
por: Wilson, Duncan T, et al.
Publicado: (2015)

Discussing end-of-life issues with terminally ill cancer patients and their families: our results
por: Eftimova, BE, et al.
Publicado: (2011)

Design of clinical cardioprotection trials using CMR: impact of myocardial salvage index and a narrow inclusion window on sample size
por: Engblom, Henrik, et al.
Publicado: (2015)

Adaptive designs for phase II cross-over dose-finding trials using Bayesian model averaging
por: Simpson, Sarah, et al.
Publicado: (2015)

Designing pulmonary arterial hypertension trials for detecting change in right ventricular function using cardiovascular magnetic resonance: what is the appropriate sample size?
por: Addetia, Karima, et al.
Publicado: (2013)

Adaptive two-stage bioequivalence trials with early stopping and sample size re-estimation
por: Koenig, Franz, et al.
Publicado: (2015)

Coping with clustering in sample size calculations
por: Playle, Rebecca, et al.
Publicado: (2011)

Lentiviral-based anti-HIV therapeutic vaccine: design, preclinical studies and phaseI/II clinical trial preliminary results
por: Bauche, Cécile, et al.
Publicado: (2014)

Mammographic interpretation training: what exactly do film-readers want?
por: Chen, Y, et al.
Publicado: (2008)

Sample size requirements for pilot randomised controlled trials with continuous outcomes: a simulation study
por: Teare, Marion, et al.
Publicado: (2013)

Determining the sample size for a cluster-randomised trial: Bayesian hierarchical modelling of the ICC estimate
por: Tishkovskaya, Svetlana, et al.
Publicado: (2015)

Pragmatic constraint-led approach to sample size
por: Silcocks, Paul, et al.
Publicado: (2015)

Smaller sample sizes for phase II trials based on exact tests with actual error rates by trading-off their nominal levels of significance and power
por: Khan, I, et al.
Publicado: (2012)

Some small sample properties of the EWOC design in dose escalation trials
por: Kinnersley, Nelson
Publicado: (2015)

A probability of benefit (AUC) approach to phase II cancer trials
por: Silcocks, Paul
Publicado: (2015)

Modifying the multi-arm multi-stage (MAMS) design for use in a phase II tuberculosis trial in sub-Saharan Africa with a time-to-event primary outcome
por: Phillips, Patrick, et al.
Publicado: (2013)

The importance of planning for a seamless transition in an adaptive phase II randomised trial
por: Marshall, Andrea, et al.
Publicado: (2011)

Phase I/II clinical trial of anti-OX40, radiation and cyclophosphamide in patients with prostate cancer: immunological analysis
por: Kovacsovics-Bankowski, Magdalena, et al.
Publicado: (2013)

Practical implementation of an adaptive phase I/II design in chronic myeloid leukaemia: evaluating both efficacy and toxicity using the EffTox design
por: Khan, Josephine, et al.
Publicado: (2013)

Simplification or simulation: some unclear issues in sample size calculation
por: Huang, Chao
Publicado: (2013)

The use of historical priors to improve the efficiency of phase II clinical trials with time-to-event endpoints
por: Jackson, Richard, et al.
Publicado: (2013)

Sources of variability in quantification of CMR infarct size and their impact on sample size calculations - reproducibility among three core laboratories
por: Klem, Igor, et al.
Publicado: (2015)

Assessing individual equivalence in parallel group and crossover designs: Exact test and sample size procedures
por: Shieh, Gwowen
Publicado: (2022)

Sample size determination through power simulation; practical lessons from a stepped wedge cluster randomised trial (SW CRT)
por: Dimairo, Munyaradzi, et al.
Publicado: (2011)

Optimising the design of internal pilot work to inform efficient randomised controlled trials: issues to consider when developing progression criteria
por: Avery, Kerry, et al.
Publicado: (2015)

Correcting for selection bias in two-stage trials with multiple correlated outcomes: application to seamless phase ii/iii clinical trials
por: Robertson, David, et al.
Publicado: (2015)

INTERVENTIONAL PULMONOLOGY AND ISSUES RELATED TO THE LUNG SURGERY
Publicado: (2022)

Sample size calculation for clinical trials using cardiac magnetic resonance partition coefficient and extracellular volume fraction for the assessment of diffuse myocardial fibrosis
por: Liu, Songtao, et al.
Publicado: (2013)

Identifying appropriate phase II trial designs
por: Brown, Sarah R
Publicado: (2011)

A better way to determine sample size to detect changes in length of mechanical ventilation?
por: Chiew, YS, et al.
Publicado: (2015)

Calculating the design effect for a cluster stepped-wedge trial with varying cluster size; a case study from a trial in type 2 diabetes
por: Ashra, Nuzhat, et al.
Publicado: (2015)

Exploring non-compliance in a cluster randomised feasibility study to inform the design of the phase III trial
por: Bell, Lauren, et al.
Publicado: (2015)

Challenges in the design and analysis of surgical trials
por: Rombach, Ines, et al.
Publicado: (2013)

Improving phase ii oncology trial using best observed RECIST response as an endpoint by modelling continuous tumour measurements
por: Lin, Chien-Ju, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_h1gikbr9mlai6i1o5vhmomo59j